| Voice for health: the use of vocal biomarkers from research to clinical practice G Fagherazzi, A Fischer, M Ismael, V Despotovic Digital biomarkers 5 (1), 78-88, 2021 | 150 | 2021 |
| New HIV diagnoses among adults aged 50 years or older in 31 European countries, 2004–15: an analysis of surveillance data L Tavoschi, JG Dias, A Pharris, D Schmid, A Sasse, D Van Beckhoven, ... The lancet HIV 4 (11), e514-e521, 2017 | 139 | 2017 |
| Uncommon mutations at residue positions critical for enfuvirtide (T-20) resistance in enfuvirtide-naive patients infected with subtype B and non-B HIV-1 strains F Roman, D Gonzalez, C Lambert, S Deroo, A Fischer, T Baurith, T Staub, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 33 (2), 134-139, 2003 | 61 | 2003 |
| Long COVID symptomatology after 12 months and its impact on quality of life according to initial coronavirus disease 2019 disease severity A Fischer, L Zhang, A Elbéji, P Wilmes, P Oustric, T Staub, PV Nazarov, ... Open Forum Infectious Diseases 9 (8), ofac397, 2022 | 54 | 2022 |
| Long COVID classification: findings from a clustering analysis in the predi-COVID cohort study A Fischer, N Badier, L Zhang, A Elbéji, P Wilmes, P Oustric, C Benoy, ... International Journal of Environmental Research and Public Health 19 (23), 16018, 2022 | 43 | 2022 |
| Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as … S Lambert-Niclot, EC George, A Pozniak, E White, C Schwimmer, ... Journal of Antimicrobial Chemotherapy 71 (4), 1056-1062, 2016 | 43 | 2016 |
| Is the Vpr R77Q mutation associated with long-term non-progression of HIV infection? A Fischer, C Lejczak, C Lambert, F Roman, J Servais, E Karita, S Allen, ... Aids 18 (9), 1346-1347, 2004 | 31 | 2004 |
| HIV Type 1 pol Gene Diversity and Archived Nevirapine Resistance Mutation in Pregnant Women in Rwanda J Servais, C Lambert, E Karita, D Vanhove, A Fischer, T Baurith, ... AIDS research and human retroviruses 20 (3), 279-283, 2004 | 31 | 2004 |
| Injection of cocaine is associated with a recent HIV outbreak in people who inject drugs in Luxembourg V Arendt, L Guillorit, A Origer, N Sauvageot, M Vaillant, A Fischer, ... PloS one 14 (5), e0215570, 2019 | 30 | 2019 |
| Antiviral efficacy and resistance in patients on antiretroviral therapy in Kigali, Rwanda: the real‐life situation in 2002 A Fischer, JC Karasi, D Kibibi, C Omes, C Lambert, A Uwayitu, R Hemmer, ... HIV medicine 7 (1), 64-66, 2006 | 30 | 2006 |
| Protocol for a prospective, longitudinal cohort of people with COVID-19 and their household members to study factors associated with disease severity: the Predi-COVID study G Fagherazzi, A Fischer, F Betsou, M Vaillant, I Ernens, S Masi, ... BMJ open 10 (11), e041834, 2020 | 27 | 2020 |
| Neutralising properties of peptides derived from CXCR4 extracellular loops towards CXCL12 binding and HIV-1 infection A Chevigné, V Fievez, M Szpakowska, A Fischer, M Counson, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1843 (5), 1031-1041, 2014 | 27 | 2014 |
| Systematic review and network meta-analysis of the efficacy of existing treatments for patients with recurrent glioblastoma A Schritz, N Aouali, A Fischer, C Dessenne, R Adams, G Berchem, ... Neuro-Oncology Advances 3 (1), vdab052, 2021 | 25 | 2021 |
| Associations between physical activity prior to infection and COVID-19 disease severity and symptoms: results from the prospective Predi-COVID cohort study L Malisoux, A Backes, A Fischer, G Aguayo, M Ollert, G Fagherazzi BMJ open 12 (4), e057863, 2022 | 19 | 2022 |
| Methods to generate innovative research ideas and improve patient and public involvement in modern epidemiological research: review, patient viewpoint, and guidelines for … GA Aguayo, C Goetzinger, R Scibilia, A Fischer, T Seuring, VT Tran, ... Journal of Medical Internet Research 23 (12), e25743, 2021 | 19 | 2021 |
| Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected … L Dickinson, R Gurjar, W Stöhr, S Bonora, A Owen, A D’avolio, A Cursley, ... Journal of Antimicrobial Chemotherapy 75 (3), 628-639, 2020 | 15 | 2020 |
| Non-immunized natural human heavy chain CDR3 repertoires allow the isolation of high affinity peptides mimicking a human influenza hemagglutinin epitope S Deroo, A Fischer, N Beaupain, M Counson, N Boutonnet, J Pletinckx, ... Molecular immunology 45 (5), 1366-1373, 2008 | 15 | 2008 |
| Towards precision cardiometabolic prevention: results from a machine learning, semi-supervised clustering approach in the nationwide population-based ORISCAV-LUX 2 study G Fagherazzi, L Zhang, G Aguayo, J Pastore, C Goetzinger, A Fischer, ... Scientific Reports 11 (1), 16056, 2021 | 14 | 2021 |
| Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients CM Capelle, S Ciré, O Domingues, I Ernens, F Hedin, A Fischer, ... Cell Reports Medicine 3 (4), 2022 | 13 | 2022 |
| A voice-based biomarker for monitoring symptom resolution in adults with COVID-19: Findings from the prospective Predi-COVID cohort study G Fagherazzi, L Zhang, A Elbéji, E Higa, V Despotovic, M Ollert, ... PLOS Digital Health 1 (10), e0000112, 2022 | 12 | 2022 |
